Good Morning Friends,
Following are today’s Mains Marathon Questions.
About Mains Marathon – This is an initiative of ForumIAS to help/aid aspirants in their writing skills, which is crucial to conquering mains examination.
Every morning, we post 2-3 questions based on current affairs. The questions framed are meaningful and relevant to the exam.
Write your answers in the comment box, given below.
For Mains Marathon Archives click HERE→
Questions
1) Adverse reports on Indian medicines, such as those from the Gambia, could dent the country’s well-earned reputation of being the pharmacy of the Third World. In light of the statement, discuss the steps required to maintain India’s trust in the field of Pharmaceuticals.
2) Highlight the benefits and risks of issuing a CBDC in India, with reference to the RBI’s concept note.
Answer 2
Great answer! Very balanced. Do provide a brief definition of CBDC, preferably the one used by the RBI.
There are some other challenges (not risks per se) like deciding on possible models of CBDC (like interest on CBDC, form of CBDC, degree of anonymity etc.) There are implications of each and RBI would have to take proper care in selecting a particular alternative.
Please give marks
Great answer! Overall the points are relevant. But You can elaborate them a bit more, e.g., You can highlight the ‘fragmented regulation’ regarding drug quality control in India, there are 30+ regulatory agencies in India (for each State/UT) to enforce standards, ideally there should be single regulator.
Do mention lack of adherence to ‘Good Manufacturing Practices’ (GMPs) which are vital to ensure quality drugs. Also there is issue of lack of transparency, e.g., data related to drug efficacy are not published regularly. You can refer to these issues here.
Great answer! Overall the points are relevant. But You can elaborate them a bit more, e.g., You can highlight the ‘fragmented regulation’ regarding drug quality control in India, there are 30+ regulatory agencies in India (for each State/UT) to enforce standards, ideally there should be single regulator.
Do mention lack of adherence to ‘Good Manufacturing Practices’ (GMPs) which are vital to ensure quality drugs. Also there is issue of lack of transparency, e.g., data related to drug efficacy are not published regularly. You can refer to these issues here.
Please allot marks too
Good answer! Some points are good and relevant, while others can be improved a bit.
Definition, CBDC is generic term, so don’t mention Indian Rupee there. Also You can check definition given by T Rabi Shankar, Deputy Governor of RBI.
In benefits, You can add that digital currency reduces threat of counterfeit currency. Don’t include Govt. initiatives, there are not relevant here. Don’t quote Data Protection Bill, it has been withdrawn (2019 not 2022).
Good answer! You can briefly mention the issues which are the cause of quality issues like fragmented regulation, lack of adherence to Good Manufacturing Practices (GMPs), lack of transparency on data for granting approvals etc.
Correspondingly, these points can be in appropriate suggestion. Read about some of the issues here.
Thank you, I will remember these improvements.
Good answer! You can briefly mention the issues which are the cause of quality issues like fragmented regulation, lack of adherence to Good Manufacturing Practices (GMPs), lack of transparency on data for granting approvals etc.
Correspondingly, these points can be in appropriate suggestion. Read about some of the issues here.
Good answer! Very relevant points. There is a need to reform the regulatory structure also, there are ~35 drug regulators in India (almost 1 for each State/UT) which leads to gaps. As a result adherence to standards is poor. Also many Indian pharma manufacturing plants do not follow Good Manufacturing Practices. There is lack of transparency in drug approval as well. Include all these points in solution. Read here.
Great answer! Very concise and to the point. Proper structure, you began with appropriate definition as well. In challenges, also include lack of access to means to use digital currency (internet/devices). Rest is great!